Sells infusion products and specialty pharmaceuticals to hospitals and healthcare providers.
Jun 2026Revenue $5.85M/yrExpenses $16.0M/yr
Fell below break-even Oct 2023Cash runway ≈ 2 months from Jun 2026
Figures by year
When will Quanome Technologies be profitable again?
Its expenses passed its revenue in Oct 2023. In the 12 months to Jun 2026, revenue was $5.85M and expenses $16.0M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Jun 2026 | $5.85M | $16.0M | −$10.2M |
| Jun 2025 | $2.76M | $4.25M | −$1.49M |
| Jun 2024 | $18.3M | $18.8M | −$526K |
| Jun 2023 | $12.9M | $12.6M | $247K |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.